title: Gamma knife radiosurgery for cavernous hemangiomas.
abstract: OBJECTIVE
  The authors analyzed the outcome of 53 patients with cavernous hemangiomas who underwent gamma knife radiosurgery (GKS) and evaluated the benefit of the treatment.
  
  
  METHODS
  From 1994 to 1995, 57 patients were treated with GKS for cavernous hemangiomas. The mean margin dose to the lesions was 20.3 Gy (range 14.5-25.2 Gy) and the prescription isodose was 50 to 80%. The mean follow-up period was 4.2 years. Four patients were lost to follow up. In 18 of 28 patients whose chief complaint was seizures, there was a decrease in seizure frequency. Five of 23 patients with hemorrhage suffered rebleeding 4 to 39 months after GKS. Seventeen patients in whom the hemangiomas were located at the frontal or parietal lobe had neurological disability and in five this was severe. Two patients underwent resection of their hemangioma after GKS. Three experienced visual problems. Follow-up imaging demonstrated shrinkage of the lesion in 19 patients.
  
  
  CONCLUSIONS
  A higher margin dose (> 16 Gy) may be associated with a reduction in the incidence of rebleeding after GKS. Higher dosage and severe brain edema after GKS may decrease the frequency and intensity of seizures at least temporarily. Gamma knife radiosurgery may play a role in protection against hemorrhage and in reduction of the rate of seizure in selected cases with the appropriate dose.
authors.affiliation: Department of Neurosurgery, Shanghai Gamma Knife Hospital and Shanghai Huashan Hospital, People's Republic of China. nanzhang@sina.com
authors.forename: N
authors.initials: N
authors.lastname: Zhang
authors.forename: L
authors.initials: L
authors.lastname: Pan
authors.forename: B J
authors.initials: BJ
authors.lastname: Wang
authors.forename: E M
authors.initials: EM
authors.lastname: Wang
authors.forename: J Z
authors.initials: JZ
authors.lastname: Dai
authors.forename: P W
authors.initials: PW
authors.lastname: Cai
mesh_terms: D000293:Adolescent; D000328:Adult; D001921:Brain / Q000473:pathology; D001932:Brain Neoplasms / Q000473:pathology / Q000601:surgery*; D002426:Cavernous Sinus / Q000473:pathology / Q000601:surgery*; D002648:Child; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D020786:Hemangioma, Cavernous, Central Nervous System / Q000473:pathology / Q000601:surgery*; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000209:etiology / Q000601:surgery; D016634:Radiosurgery; D012086:Reoperation